Shiksha Nation
Skip to content

Amyloid-related imaging abnormalities

Medical condition

  • 1 min read
  • 4 chapters

Related on Lably

Through Alzheimer's disease, Confusion and Bleeding

ARIA-E

ARIA-E refers to cerebral edema, involving the breakdown of the tight endothelial junctions of the blood-brain barrier and subsequent accumulation of fluid. In a double-blind trial of the humanised monoclonal antibody solanezumab (n = 2042), sixteen patients (11 taking the drug, 5 taking a placebo), or 0.78% developed ARIA-E. A further 7 patients developed ARIA-E during an open-label extension of the trial.

The effect of ARIA-E depends on the severity and location of the edema. Symptoms may include headache, changes in mental state, confusion, vomiting, nausea, tremor and gait disturbances.

Sign up free to read the rest

3 more chapters are free with a Lably account.

Already have an account?

More in Neuroscience